18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.

Fengxian ZhangXiaodong WuJunjie ZhuYan HuangXiao SongLei Jiang

Published in: European journal of nuclear medicine and molecular imaging (2021)

18F-FDG PET/CT was superior to CTCs in the diagnosis of treatment-naive patients with NSCLC. The levels of CTCs in the peripheral blood were associated with tumor glucose metabolism in NSCLC. Metabolic parameters of 18F-FDG PET/CT and CTCs could separately predict the outcomes of treatment-naive patients with NSCLC.

Keyphrases

circulating tumor cells
small cell lung cancer
peripheral blood
metabolic syndrome
combination therapy
epidermal growth factor receptor
tyrosine kinase